Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Alys Hall who wrote (767)	11/28/1997 1:11:00 PM
From: cjgaddy	Read Replies (3) \| Respond to of 3702

CBS/Rather News WED. nite had a 5-min special on Idec's RITUXAN. It was VERY POSITIVE and featured a lady doctor that herself has NHL and has been "put into total remission" by Rituxan, with no side effects. They said it had been approved and would be available soon. They mentioned the term "monoclonal antibodies" and said something about the using the body's own immune system to fight cancer. They never mentioned IDEC by name, and also said that "other companies" had further solutions on the horizon. Did anyone else see this? The 1st thing that hit me as I was watching it was "Well, this is it - the public is going to get drift of this and it's gonna send TCLN to the moon"!! Wait just a little longer: I'm trying to raise a few bucks to buy some more while it's still cheap! Take care, Jack.